In collective resistance, microbial communities are able to survive antibiotic exposures that would be lethal to individual cells. In this review, we explore recent advances in understanding collective resistance in bacteria. The population dynamics of "cheating" in a system with cooperative antibiotic inactivation have been described, providing insight into the demographic factors that determine resistance allele frequency in bacteria. Extensive work has elucidated mechanisms underlying collective resistance in biofilms and addressed questions about the role of cooperation in these structures. Additionally, recent investigations of "bet-hedging" strategies in bacteria have explored the contributions of stochasticity and regulation to bacterial phenotypic heterogeneity and examined the effects of these strategies on community survival.
Introduction
The mechanisms that confer antibiotic resistance in microbes are well understood on the level of the individual cell [1] . However, it is increasingly apparent that the social dynamics of microbes can affect the outcome of antimicrobial chemotherapy, and there has been considerable recent progress in identifying the population-level processes that affect antibiotic response.
In this review, we focus on how a community of bacteria can survive antimicrobial therapy where a single bacterium cannot. For the purposes of this review, we define a microbial "community" as a collection of microorganisms within which different phenotypes and/or genotypes coexist. We discuss recent work in collective resistance in bacteria via cooperative inactivation of antibiotics, where population dynamics within communities are shown to play a role in determining the prevalence of antibiotic resistance genes. Further, we review recent advances in biofilm ecology that demonstrate the importance of spatial structure and cooperation for antibiotic resistance in these structures. Finally, we consider current theories of stochastic and responsive phenotypic diversity, with a focus on signaling within communities and interactions between communities and their environment as factors controlling the emergence of antibiotic-tolerant phenotypes. For each of these topics, we explore the implications for antimicrobial chemotherapy.
Cooperative Resistance
Dense populations of bacteria resist eradication by drug concentrations considerably greater than those required to kill the same population at a lower density [2] in a phenomenon known as the "inoculum effect". One mechanism for density-dependent antibiotic efficacy is drug inactivation by bacterially expressed resistance enzymes (Figure 1a,b) .. The population's collective capacity to inactivate the drug depends upon several factors, including the number of cells expressing the enzyme conferring resistance. Cooperative resistance is therefore expected to be less effective at small initial population sizes, resulting in separation between the minimum antibiotic concentration required to affect single cells and the canonical MIC (Figure 1c) , which is typically measured using relatively high inocula (~10 6 CFU/mL) [3] [T. Artemova, unpublished] .
Enzymatic inactivation of antibiotic can lower the environmental antibiotic concentration, allowing sensitive cells in that environment to survive (Figure 1d ). Indeed, cooperative inactivation of β-lactam antibiotics and protection of sensitive cells occurs with some regularity in natural microbial communities [4] . In these communities, antibiotic-sensitive bacteria can be regarded as "cheaters" which benefit from resistance without incurring the metabolic cost of enzyme production.
Experimental evidence from synthetic microbial systems has demonstrated that, in a community where cooperative resistance alleles exist prior to antibiotic treatment, cheating can drive the population dynamics of the resistance allele [3] . Antibiotic inactivation may be thought of as a common goods problem, where the dynamics of these mixed populations depend on whether resistance enzyme production has a fitness cost. When resistance carries a cost, the system is vulnerable to cheating -sensitive bacteria may grow more quickly than resistant cells once the antibiotic concentration drops beneath their MIC [5] , resulting in a decrease in the proportion of resistant cells [3] . However, evolution of compensatory mechanisms can occur rapidly, minimizing the cost of resistance and stabilizing the resistance allele [3, 6] .
Collective resistance can occur when cells do not express antibiotic-inactivating enzymes. For example, a recent study has demonstrated a mechanism for inoculum effects during aminoglycoside treatment of sensitive Escherichia coli; here, the amount of antibiotic per cell determines whether individual cells grow or die, resulting in density-dependent bistability in the outcome of antibiotic treatment [2] . In this case the cells are acting as "sinks" for the antibiotic, resulting in effective cooperation by load-sharing between cells in the population. Collective resistance in dense bacterial populations is therefore likely to be a ubiquitous feature that will require new measurements, analyses, and treatments.
Biofilm-Associated Resistance
Density-dependent collective resistance is also characteristic of structured environments such as surface-associated biofilms. These structures are ubiquitous in nature, probably representing the most common structured bacterial environment in the natural world, and are notoriously difficult to eradicate in settings from industry to the clinic [7] . Bacteria within biofilms can show remarkable decreases in susceptibility to antibiotics and other toxins, resisting drug concentrations much higher than those required to kill free-living bacteria at comparable densities [8] . Together with cell density, spatial organization and the physical structure itself can all contribute to resistance.
The structure and composition of the biofilm matrix can contribute to resistance. Exopolysaccharide and extracellular DNA in the biofilm matrix can act as a barrier to diffusion, preventing drugs from reaching living cells (Figure 2a ) [9] . The effectiveness of this barrier varies between antibiotics -large molecules, positively charged aminoglycosides, and antimicrobial peptides diffuse poorly in biofilms, but quinolones and β-lactams appear to move freely [10, 11] .
For antibiotics that can penetrate the matrix, inactivation by resistance enzymes can produce collective resistance as described in the previous section ( Figure 2b ) [12] . Enzymatic inactivation of antibiotics in the outer regions of a biofilm can prevent drugs from reaching deeper layers, potentially allowing sensitive bacteria in these regions to survive. Resistance enzyme-expressing bacteria can therefore occupy a spatial niche near the biofilm surface, where concentrations of drugs as well as oxygen and other nutrients will be highest [13, 14] . Here, spatial organization can decrease the cost of resistance enzyme production by allowing preferential access to resources, while simultaneously allowing less-resistant bacteria to survive in a detoxified environment. Consistent with this idea, increases in resistance plasmid copy number and hyperexpression of antibiotic-inactivating enzymes occur heterogeneously in biofilm-associated Enterococcus faecalis, increasing resistance in the biofilm as a whole [15] .
Antibiotics that do reach the deep layers of a biofilm may be less effective due to conditions generated by bacterial metabolism and diffusion limitation. These processes create gradients in oxygen, cations, and other solutes as well as pH, which can affect the uptake and efficacy of antibiotics [16, 17] . (Figure 2c ). Moreover, slow or arrested cell growth deep in the biofilm is known to decrease antibiotic susceptibility in biofilms (Figure 2d ) [18] , and metabolic responses to nutrient limitation may control antibiotic tolerance in growtharrested cells under these conditions [19, 20] .
Metabolic cooperation within biofilms can also promote antibiotic resistance. This has been observed in polymicrobial biofilms [21] , probably due in part to increased productivity and matrix thickness in these assemblies [22] . Diversity in biofilms may therefore imply a sort of division of labor [23] where mutualistic interactions between taxa produce net gains in total productivity.
As observed previously for cooperative antibiotic degradation, cooperation in biofilms is vulnerable to exploitation by cheating [24] . Biofilm assembly may be thought of as a common goods problem, where membership in the communal structure is advantageous but production and maintenance of the structure is costly. When an excess of cheaters is present, the protective capacity of the collective structure is diminished [24, 25] , and the entire structure may be lost.
Phenotypic Heterogeneity and Signaling
Collective resistance need not be "cooperative" in a normal sense; instead, phenotypic variation within isogenic bacterial populations can act as a risk-buffering or "bet-hedging" strategy by generating stress-resistant variants [26,27] ( Figure 3 ). There is an observed trade-off between growth rate and robustness of individual cells [27] , and stress-resistant "persister" phenotypes show reduced or arrested growth under permissive conditions but survive and re-grow after antibiotic treatment [18] . Importantly, the resulting population of cells restores the original distribution of stress-sensitive and stress-resistant phenotypes, demonstrating that the rare survivors were not genetically resistant to the antibiotic [28] . This diversity allows the community to survive environmental changes that would kill off individual cells, increasing the community's long-term fitness in a variable environment.
Though bet-hedging only requires increased survival of variant phenotypes, generation of stress-tolerant phenotypes can also protect the population as a whole. In the case of Staphylococcus aureus, stochastic differentiation produces reversibly gentamycin-resistant small colony variants (SCVs) which divide slowly but can grow in the presence of antibiotic [29] . Interestingly, the by-products of SCV fermentation alter environmental pH, reducing the efficacy and uptake of gentamycin. As a result, SCV frequency increases initially and then declines in favor of wild-type revertants as the environment becomes more permissive.
In S. aureus, stress-tolerant phenotypes are generated and reversed stochastically, at rates that do not depend on environmental conditions [38] . 
Conclusions
Community-based resistance presents challenges and opportunities for antimicrobial chemotherapy. We have seen that community-based resistance often relies on cooperation, which can be disrupted by cheating; weakening cooperative links within collectivelyresistant communities may therefore reduce their protective effects. In particular, the recalcitrance of biofilms is being addressed from an ecological standpoint in efforts to disrupt these communities and remove the protection of the collective, including methods for interfering with inter-cell signaling [41, 42] . Inhibition of microbial cooperation is a promising pathway for treatment regimes that minimize collective resistance; continued discovery of new inhibitors and deployment of these compounds against antibioticrecalcitrant communities will show how likely this promise is to be realized. Few attempts have been made to directly address cooperative inactivation of antibiotics or taxonomic diversity as mechanisms of collective resistance. Current efforts rely heavily on empirical treatment regimes, using a set of antibiotics targeted to the vulnerabilities of individual taxa [49] or otherwise targeting multiple vulnerabilities within a system [50] [51] [52] [53] [54] to provide ad hoc means of navigating a landscape of unknown defenses. For cooperatively resistant communities containing resistance alleles and/or multiple taxa, it may be possible to design more precise treatments that disrupt ecological interactions (removing key portions of the community or more broadly reducing diversity) with the aim of reducing overall resistance.
More work is needed to develop therapies for eradication of physiologically heterogeneous bacterial communities. Regulation of phenotypic differentiation has been targeted in attempts to prevent or reverse formation of stress-resistant variants, and there have been promising recent advances targeting bacterial metabolism and signaling to reduce phenotypic tolerance through environmental regulation [55] [56] [57] . Additionally, increased understanding of metabolism in phenotypic variants has raised the possibility of treatments that can specifically eradicate these cells [20, 56, 57] , potentially allowing elimination of persistent infections.
It may be possible to address stochastic differentiation in its ecological context. Selective forces are expected to tune rates and regulatory mechanisms of bet-hedging to the expected environmental variation. Random switching is expected to fare well in environments with rare, sudden fluctuations, while reliable environmental signaling is expected to favor regulation [33, 35] . Recent work [35] has expanded theories for the evolution of bet-hedging strategies into scenarios incorporating spatial structure and population density; here, success of a strategy depends on the size and composition of the local community, indicating that the ecological context can affect how bet-hedging strategies are evolved. As our understanding of stochastic differentiation increases, it may be possible to estimate current fitness and evolutionary trajectories of bet-hedging strategies in different environments, and ultimately even to design therapies to counter the full range of physiological adaptation.
community where each species produces a different common good (food or detoxification 
Highlights
• Bacterial communities survive antimicrobial therapy where individuals cannot.
• This effect can be produced by cooperative inactivation of antibiotics.
• Biofilms produce community-and drug-dependent collective resistance.
• Bet-hedging allows community survival in variable environments.
• Collective resistance offers opportunities for new therapeutic approaches.
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Figure 1. Enzymatic inactivation of antibiotics allows cooperative resistance
(a) When a resistance enzyme (blue) is expressed (from a resistance plasmid, red), the amount of antibiotic (green squares) inside the cell is determined by the balance between flux and inactivation (inactivated antibiotic, green 3/4 square). If the intracellular concentration is below some critical threshold at a given external concentration of drug, the cells will survive and grow; otherwise, the cells will die. (b) The outcome of antibiotic treatment depends on cell density and resistance enzyme production. Starting resistant cell density determines whether the population will be able to inactivate enough of the drug to allow re-growth before it is driven to extinction. (c) This results in density-dependent changes in the external concentration of drug that is sufficient to prevent re-growth (called the minimum inhibitory concentration or MIC), characteristic of the inoculum effect. (d) Cooperative inactivation can protect sensitive cells which do not carry the resistance gene, and the population structure after re-growth may be very different from the starting structure due to fitness differences between sensitive cells and cells expressing the resistance enzyme. 
